| World report on hearing World Health Organization World Health Organization, 2021 | 1235 | 2021 |
| WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination R Faden, O Saad, S Kochhar, D Kaslow, S Pallas, F Olayinka, M Afolabi, ... World Health Organization, 2020 | 221 | 2020 |
| Relationship between depression and quality of life in persons with HIV infection in Nigeria AO Adewuya, MO Afolabi, BA Ola, OA Ogundele, AO Ajibare, BF Oladipo, ... The International Journal of Psychiatry in Medicine 38 (1), 43-51, 2008 | 179 | 2008 |
| Prevalence of chronic kidney disease in a Nigerian family practice population MO Afolabi, EA Abioye-Kuteyi, FA Arogundade, IS Bello South African Family Practice 51 (2), 132-137, 2009 | 164 | 2009 |
| Psychiatric disorders among the HIV-positive population in Nigeria: a control study AO Adewuya, MO Afolabi, BA Ola, OA Ogundele, AO Ajibare, BF Oladipo Journal of psychosomatic research 63 (2), 203-206, 2007 | 146 | 2007 |
| Post-traumatic stress disorder (PTSD) after stigma related events in HIV infected individuals in Nigeria AO Adewuya, MO Afolabi, BA Ola, OA Ogundele, AO Ajibare, BF Oladipo, ... Social psychiatry and psychiatric epidemiology 44, 761-766, 2009 | 107 | 2009 |
| Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and … Caroline Ogwang, Muhammed Afolabi, Domtila PLoS One 8 (3), 1-11, 2013 | 105* | 2013 |
| Risk factors for delay in age-appropriate vaccinations among Gambian children A Odutola, MO Afolabi, EO Ogundare, YN Lowe-Jallow, A Worwui, ... BMC health services research 15, 1-9, 2015 | 100 | 2015 |
| Informed consent comprehension in A frican research settings MO Afolabi, JU Okebe, N McGrath, HJ Larson, K Bojang, ... Tropical medicine & international health 19 (6), 625-642, 2014 | 91 | 2014 |
| Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non … D Ishola, D Manno, MO Afolabi, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 97-109, 2022 | 83 | 2022 |
| Ebola: a holistic approach is required to achieve effective management and control A Roca, MO Afolabi, Y Saidu, B Kampmann Journal of Allergy and Clinical Immunology 135 (4), 856-867, 2015 | 82 | 2015 |
| Safety and immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants MO Afolabi, AB Tiono, UJ Adetifa, JB Yaro, A Drammeh, I Nébié, C Bliss, ... Molecular therapy 24 (8), 1470-1477, 2016 | 80 | 2016 |
| Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ... Molecular Therapy 22 (11), 1992-2003, 2014 | 76 | 2014 |
| Safety and immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial MO Afolabi, D Ishola, D Manno, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 110-122, 2022 | 75 | 2022 |
| Coverage and timing of children's vaccination: an evaluation of the expanded programme on immunisation in the Gambia S Scott, A Odutola, G Mackenzie, T Fulford, MO Afolabi, YL Jallow, ... PloS one 9 (9), e107280, 2014 | 67 | 2014 |
| The effect of psychological distress on medication adherence in persons with HIV infection in Nigeria AO Adewuya, MO Afolabi, BA Ola, OA Ogundele, AO Ajibare, BF Oladipo, ... Psychosomatics 51 (1), 68-73, 2010 | 66 | 2010 |
| Lessons from the Ebola epidemics and their applications for COVID‐19 pandemic response in sub‐Saharan Africa MO Afolabi, MO Folayan, NS Munung, A Yakubu, G Ndow, A Jegede, ... Developing world bioethics 21 (1), 25-30, 2021 | 64 | 2021 |
| Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants CM Bliss, A Drammeh, G Bowyer, GS Sanou, YJ Jagne, O Ouedraogo, ... Molecular Therapy 25 (2), 547-559, 2017 | 63 | 2017 |
| Pattern of depression among patients in a Nigerian family practice population MO Afolabi, EA Abioye-Kuteyi, FO Fatoye, IS Bello, AO Adewuya South African Family Practice 50 (2), 63-63, 2008 | 61 | 2008 |
| Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria MO Afolabi, KT Ijadunola, AO Fatusi, OA Olasode African Journal of Primary Health Care and Family Medicine 1 (1), 1-6, 2009 | 60 | 2009 |
